Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis

Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease often requiring long-term treatment. Crisaborole significantly improved global AD signs and symptoms in 28-day phase 3 studies of patients aged ≥ 2 years with mild-to-moderate AD (Investigator’s Static Global Assessment [ISGA...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Dermatology and therapy 2021-10, Vol.11 (5), p.1667-1678
Hauptverfasser:	Geng, Bob, Hebert, Adelaide A., Takiya, Liza, Miller, Lauren, Werth, John L., Zang, Chuanbo, Sanders, Paul, Lebwohl, Mark G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged patients Atopic dermatitis Care and treatment Dermatology Diagnosis Internal Medicine Medicine Medicine & Public Health NCT NCT02118766,NCT02118792 Oral and Maxillofacial Surgery Original Research Plastic Surgery Quality of Life Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!